The net loss and the weighted average number of shares of common stock and pre-funded warrants used in computing basic and diluted net loss per share for the three and six months ended June 30, 2026 and 2025, are as follows (in thousands, except share and per share data):


	Three Months Ended June 30,						Six Months Ended June 30,
	2026			2025			2026			2025
Numerator:
Net loss	$	(4,502	)	$	(1,891	)	$	(8,256	)	$	(3,600	)
Denominator:
Weighted average number of shares of common stock and pre-funded warrants used in computing net loss per share, basic and diluted		6,789,165			347,000			5,592,596			346,482
Net loss per share, basic and diluted	$	(0.66	)	$	(5.45	)	$	(1.48	)	$	(10.39	)

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as their effect would be anti-dilutive:


	Six Months Ended June 30,
	2026		2025
Options to purchase common stock		1,048,407		27,038
Restricted stock units, unvested portion		2,067		7,020
Restricted stock awards, unvested portion		13,067		20,906
Common warrants		50,402		50,402
Total potential common stock equivalents		1,113,943		105,366

The outstanding pre-funded warrants are exercisable for only a de minimis cash consideration with no substantive exercise contingencies, accordingly, the Company included pre-funded warrants in the weighted average shares outstanding for both basic and diluted earnings per share calculations.